Doximity, Inc. (DOCS)
19.26
-0.32
(-1.63%)
USD |
NYSE |
May 19, 16:00
19.26
0.00 (0.00%)
After-Hours: 20:00
Doximity Research and Development Expense (Quarterly) : 39.11M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| American Well Corp. | 12.38M |
| Claritev Corp. | -- |
| DarioHealth Corp. | 2.385M |
| Retrieve Medical Holdings, Inc. | -- |
| GoodRx Holdings, Inc. | 30.18M |